Transparency Market Research in its new report titled, “Recombinant Ingredient Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” provides key insights on the recombinant ingredient market. The new report anticipates that the increasing demand for less toxic pharmaceutical products, increase in the number of genetic disease, and manufacturing of medicine for targeted diseases will drive the recombinant ingredient market during the forecast period i.e, 2017 – 2025. As the recombinant ingredient technology has numerous applications in different fields, the drivers of the market are specific to the fields. According to the report, the primary driving factor in medicine field is the increase in the number of life-threatening diseases and the rising number of diseased population worldwide. The only restraint the TMR report believes in the recombinant ingredient market is the ethical issues concerning the approval of the recombinant products.
Recombinant DNA technique is applied to map, identify, and sequence the genes and also to recognize their functions. In addition, recombinant DNA technique is used to manipulate organisms and also the product that has been derived from these organisms. The recombinant ingredient products provide a substantial quantity, with tailor-made products whose expression can be controlled and resistant to natural inhibitors and can be utilized widely. The common recombinant DNA products in medicine are recombinant human insulin, recombinant growth hormones (HGH and somatotropin), recombinant hepatitis B vaccine, and recombinant blood clotting factor VIII.
The TMR report has segregated the recombinant ingredient market in accordance with application, end-user, and geography. In terms of application, the recombinant ingredient market is split into proteins, monoclonal antibodies, vaccines, hormones, and blood related factors. On the basis of end-user, the recombinant ingredient market is divided into biotechnology research companies, diagnostic centers, forensic labs, agriculture institutes, food industry, and hospitals.
On the basis of regional perspective, the recombinant ingredient market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. TMR, in terms of geography, states that North America and Europe are dominant in the recombinant ingredient market as biotechnology companies are growing rapidly in these regions. The U.S. is a highly attractive market as the companies in the country are research orientated and USFDA approval products can be used commercially worldwide. The emerging markets are Asia Pacific, Latin America, Middle East and Africa pertaining to developing economic scenario and increasing demand of therapeutic market. Prominent players are attracted to these regions owing to their developing economies with a strategic view to increase their productivity and expansion of business.
Major players operating in the recombinant ingredient market are profiled in this report and these include Genentech, Inc., Eli Lilly and company, Novo Nordisk, Sanofi, Biocon, Novartis AG, Pfizer, GlaxoSmithKline plc., Merck & Co. Inc., and Amgen Inc.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: [email protected]